Clinical Trials in Washington

Showing 6301-6320 of 9,462 trials

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

NCT02074410

The purpose of this study is to determine the safety, tolerability and pharmacokinetics of OMS643762 (the study drug) in subjects with Huntington's disease (HD).

Huntington's Disease

Omeros Corporation22 participantsStarted Jan 2014

San Diego, California, United States • Englewood, Colorado, United States • Gainesville, Florida, United States +6 more locations

COMPLETEDPhase 340 miles

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

NCT00838201

The purpose of this study is to describe the safety and tolerability of up to 5 years (ie, 3 years under the 20040138 Amgen study and 2 years on this study) denosumab administration as measured by adverse events, immunogenicity, and safety laboratory parameters in subjects who previously received denosumab for non-metastatic prostate cancer.

CancerCarcinomaCastrate-Resistant Prostate Cancer+2 more

Amgen384 participantsStarted Feb 2009

Huntsville, Alabama, United States • Anaheim, California, United States • Laguna Hills, California, United States +71 more locations

Safety and Efficacy of OMS643762 in Subjects With Huntington's Disease

Extension Study to Evaluate Long Term Safety of Denosumab in Subjects Undergoing ADT for Non-Metastatic Prostate Cancer

Find Trials by Condition in Washington

Alpha 1 Anti-Trypsin (AAT) in Treating Patients With Acute Graft-Versus-Host Disease GVHD)

Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis

Immunogenicity of Off-Schedule Dosing of HPV Vaccine

Safety and Efficacy of OMS103HP-S Administered in Joint Irrigation Solution to Subjects Undergoing Arthroscopic Meniscectomy

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Urinary Tract Infection (cUTI)

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

PEDS-C: Pegylated Interferon +/- Ribavirin for Children With Hepatitis C

Study of Team Leadership Training Effect on Patient Care

Power Over Pain (POP) Study

Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma

A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza Infection

BKM120 for Patients With PI3K-activated Tumors

A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer

An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

A Phase II, Study To Evaluate The Efficacy And Safety Of PH-797804 In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD).

Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Safety and Tolerability Study of MEDI-551, a B-cell Depleting Agent, to Treat Relapsing Forms of Multiple Sclerosis